Tech Company Financing Transactions
XDx Funding Round
XDx, based in Brisbane, secured $12.5 million in funding from GE Healthcare Financial Services.
Transaction Overview
Company Name
Announced On
1/28/2011
Transaction Type
Debt
Amount
$12,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing provides the company with working capital to expand the commercialization of its FDA-cleared, innovative, non-invasive AlloMap® molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases, including lupus.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3260 Bayshore Blvd.
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Website
Email Address
Overview
XDx is a molecular diagnostics company, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Maag
Chief Medical Officer
James Yee
Chief Scientific Officer
John Sninsky
VP - Bus. Development
Matthew Meyer
VP - R & D
Mitch Nelles
Browse more venture capital transactions:
Prev: 1/28/2011: Meritage Pharma venture capital transaction
Next: 1/28/2011: HelioVolt venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs